Holen Sie sich die Stockscreener-App
7.00
1.75%
-0.125
Handel nachbörslich:
7.19
0.19
+2.71%
Schlusskurs vom Vortag:
$7.125
Offen:
$7.13
24-Stunden-Volumen:
24,367
Relative Volume:
0.11
Marktkapitalisierung:
$22.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-68.80M
KGV:
-5.9829
EPS:
-1.17
Netto-Cashflow:
$-59.06M
1W Leistung:
+1.45%
1M Leistung:
+21.95%
6M Leistung:
+1,546%
1J Leistung:
+917.00%
1-Tages-Spanne:
$6.90
$7.20
1-Wochen-Bereich:
$6.63
$7.5362
52-Wochen-Spanne:
$0.257
$7.75
Passage Bio Inc Stock (PASG) Company Profile
Firmenname
Passage Bio Inc
Sektor
Branche
Telefon
(267) 866-0312
Adresse
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Vergleichen Sie PASG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
7.00 | 22.60M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-29 | Fortgesetzt | Wedbush | Outperform |
| 2024-09-03 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-03-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-19 | Herabstufung | Goldman | Buy → Neutral |
| 2021-07-01 | Eingeleitet | Raymond James | Outperform |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-03-04 | Hochstufung | Goldman | Neutral → Buy |
| 2021-02-04 | Eingeleitet | Guggenheim | Buy |
| 2021-01-25 | Eingeleitet | Wedbush | Outperform |
| 2021-01-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-08-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-06-25 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-03-24 | Eingeleitet | Cowen | Outperform |
| 2020-03-24 | Eingeleitet | Goldman | Buy |
| 2020-03-24 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Passage Bio Inc Aktie (PASG) Neueste Nachrichten
What’s the fair value of Passage Bio Inc. stockMarket Trend Review & Fast Momentum Stock Entry Tips - khodrobank.com
How hedge fund analytics apply to Passage Bio Inc. stockMarket Movement Recap & Technical Confirmation Alerts - Newser
Advanced analytics toolkit walkthrough for Passage Bio Inc.Weekly Trade Report & Detailed Earnings Play Strategies - Newser
Combining price and volume data for Passage Bio Inc.Earnings Growth Summary & Verified Stock Trade Ideas - Newser
Can Passage Bio Inc. recover in the next quarterTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - Newser
How to forecast Passage Bio Inc. trends using time seriesTrade Entry Summary & Weekly Breakout Stock Alerts - Newser
Long term hold vs stop loss in Passage Bio Inc.Trade Entry Report & Real-Time Stock Movement Alerts - Newser
Is now the right time to enter Passage Bio Inc.Market Growth Review & Free Growth Oriented Trading Recommendations - khodrobank.com
Real time pattern detection on Passage Bio Inc. stockJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - Newser
Will Passage Bio Inc. bounce back from current supportWeekly Profit Recap & Daily Volume Surge Signals - Newser
Analyzing Passage Bio Inc. with risk reward ratio charts2025 Analyst Calls & Smart Allocation Stock Reports - Newser
Will Passage Bio Inc. stock go up soonWeekly Profit Report & Long-Term Capital Growth Ideas - Newser
Risk adjusted return profile for Passage Bio Inc. analyzedJuly 2025 Breakouts & AI Optimized Trade Strategies - Newser
Is Passage Bio Inc. stock a hidden gemTrade Ideas & Weekly Top Gainers Alerts - khodrobank.com
Will Passage Bio Inc. stock recover after recent dropWeekly Risk Report & Safe Capital Preservation Plans - Newser
Should I buy Passage Bio Inc. stock now2025 Growth vs Value & Accurate Buy Signal Notifications - khodrobank.com
When is the best time to exit Passage Bio Inc.Profit Target & Daily Technical Forecast Reports - Newser
Can Passage Bio Inc. outperform in the next rallyQuarterly Portfolio Summary & Verified Stock Trade Ideas - khodrobank.com
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet - MSN
Chart overlay techniques for tracking Passage Bio Inc.Weekly Stock Analysis & Weekly Setup with High ROI Potential - Newser
How high can Passage Bio Inc. stock goTrade Analysis Summary & Safe Entry Point Identification - Newser
Is it time to cut losses on Passage Bio Inc.Portfolio Risk Summary & Growth Focused Entry Point Reports - Newser
Passage Bio Inc. Uptrend in Early Stages Indicators Say Yes getLinesFromResByArray error: size == 0 - 더경남뉴스
Historical volatility pattern of Passage Bio Inc. visualized2025 Technical Overview & Reliable Volume Spike Alerts - Newser
Technical signs of recovery in Passage Bio Inc.2025 Pullback Review & AI Powered Market Trend Analysis - Newser
Strategies to average down on Passage Bio Inc.Weekly Trade Recap & Breakout Confirmation Alerts - Newser
What indicators show strength in Passage Bio Inc.2025 Market Trends & Low Risk High Win Rate Stock Picks - Newser
Backtesting results for Boundless Bio Inc. trading strategiesJuly 2025 Short Interest & Short-Term High Return Strategies - Newser
Chart based exit strategy for Passage Bio Inc.Inflation Watch & Free Risk Controlled Daily Trade Plans - Newser
Passage Bio Inc. Volume Confirms Breakout — Analysts Bullish getLinesFromResByArray error: size == 0 - thegnnews.com
Measuring Passage Bio Inc.’s beta against major indicesIndex Update & Weekly Stock Performance Updates - Newser
Finanzdaten der Passage Bio Inc-Aktie (PASG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Passage Bio Inc-Aktie (PASG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
Jul 23 '25 |
Buy |
5.74 |
49,302 |
283,033 |
525,273 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 22 '25 |
Buy |
5.44 |
13,123 |
71,338 |
475,971 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):